Global Adrenocortical Carcinoma Treatment Market to Reach USD 1,311.89 Million by 2032 from USD 891.73 Million at 5.67% CAGR
The Global Adrenocortical Carcinoma (ACC) Treatment Market is entering a new era of precision oncology, driven by advances in biotechnology, AI-powered healthcare, genomics, and targeted cancer therapies. According to Maximize Market Research (MMR), the market was valued at USD 891.73 Million in 2025 and is projected to reach USD 1,311.89 Million by 2032, expanding at a CAGR of 5.67% during the forecast period. Rising healthcare investments, increasing clinical research, growing incidence of rare